DeepMammo selected by BioUpper
![](https://www.aigeamedical.com/wp-content/uploads/2022/02/BioUpper-800x500_c-768x480-1.jpg)
We are proud to announce that DeepMammo, the disruptive AI solution for early breast cancer detection, has been selected by BioUpper. We can’t wait to get into the empowerment go-to-market phase, that will start in the next few weeks.DeepMammo was selected as one of 10 highest value projects, from over 117 applications collected. BioUpper is […]